Literature DB >> 15353864

MaxiK channel-triggered negative feedback system is preserved in the urinary bladder smooth muscle from streptozotocin-induced diabetic rats.

Tsutomu Nakahara1, Akiko Mitani, Yuko Kubota, Takeshi Maruko, Kenji Sakamoto, Yoshio Tanaka, Katsuo Koike, Koki Shigenobu, Kunio Ishii.   

Abstract

MaxiK channel, the large-conductance Ca2+-sensitive K+ channel, facilitates a negative feedback mechanism to oppose excitation and contraction in various types of smooth muscles including urinary bladder smooth muscle (UBSM). In this study, we investigated how the contribution of MaxiK channel to the regulation of basal UBSM mechanical activity is altered in streptozotocin-induced diabetic rats. Although the urinary bladder preparations from both control and diabetic rats were almost quiescent in their basal mechanical activities, they generated spontaneous rhythmic contractions in response to a MaxiK channel blocker, iberiotoxin (IbTx). The effect of IbTx on the mechanical activity was significantly greater in diabetic rat than in control animal. Similarly, the basal mechanical activity was increased with apamin, an inhibitor for some types of small conductance Ca2+-sensitive K+ channels, and this effect was more pronounced for diabetic rat. However, in both control and diabetic animals, IbTx action was stronger than that of apamin. Diabetes also enhanced the responses to BayK 8644, an L-type Ca2+ channel agonist. The extent of this enhancement in diabetic bladder vs. control was, however, almost the same as that attained with IbTx. Expression levels for MaxiK channel as well as apamin-sensitive K+ channels and L-type Ca2+ channel were not altered by diabetes, when determined as their corresponding mRNA levels. These results indicate that diabetes can potentially increase the basal UBSM mechanical activity. However, in diabetic UBSM, the main negative-feedback system triggered by MaxiK channel is still preserved enough to counteract the possible enhancement of this smooth muscle mechanical activity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15353864     DOI: 10.1540/jsmr.40.97

Source DB:  PubMed          Journal:  J Smooth Muscle Res        ISSN: 0916-8737


  7 in total

1.  The Role of KCNMB1 and BK Channels in Myofibroblast Differentiation and Pulmonary Fibrosis.

Authors:  Anne M Scruggs; Gintautas Grabauskas; Steven K Huang
Journal:  Am J Respir Cell Mol Biol       Date:  2020-02       Impact factor: 6.914

2.  Muscarinic regulation of neonatal rat bladder spontaneous contractions.

Authors:  Yuen-Keng Ng; William C de Groat; Hsi-Yang Wu
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2006-05-18       Impact factor: 3.619

3.  Using gene chips to identify organ-specific, smooth muscle responses to experimental diabetes: potential applications to urological diseases.

Authors:  Jason D Hipp; Kelvin P Davies; Moses Tar; Mira Valcic; Abraham Knoll; Arnold Melman; George J Christ
Journal:  BJU Int       Date:  2007-02       Impact factor: 5.588

4.  Molecular cloning, tissue distribution and bioinformatics analyses of the rabbit BK channel beta1 subunit gene.

Authors:  Xiao-Yong Zhang; Sha Wang; Zhen Yan; Yi Wan; Wei Wang; Guang-Bin Cui; Pang Du; Ke-Jun Ma; Wei Han; Ying-Qi Zhang; Jing-Guo Wei
Journal:  Mol Biol Rep       Date:  2007-09-14       Impact factor: 2.316

5.  Differential effect of L-cysteine in isolated whole-bladder preparations from neonatal and adult rats.

Authors:  Hacer S G Büyüknacar; Cemil Göçmen; William C de Groat; Eda K Kumcu; Hsi-Yang Wu; Serpil Onder
Journal:  J Pharmacol Exp Ther       Date:  2010-01-05       Impact factor: 4.030

Review 6.  Central role of the BK channel in urinary bladder smooth muscle physiology and pathophysiology.

Authors:  Georgi V Petkov
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-07-02       Impact factor: 3.619

7.  Urothelial MaxiK-activity regulates mucosal and detrusor metabolism.

Authors:  Yi Wang; Gary G Deng; Kelvin P Davies
Journal:  PLoS One       Date:  2017-12-27       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.